Whole-Molecule Antibody Engineering: Generation of a High-Affinity Anti-IL-6 Antibody with Extended Pharmacokinetics-Reference-Cited by-同舟云学术

Whole-Molecule Antibody Engineering: Generation of a High-Affinity Anti-IL-6 Antibody with Extended Pharmacokinetics

Published:2011-08 Issue:4 Volume:411 Page:791-807
ISSN:0022-2836
Container-title:Journal of Molecular Biology
language:en
Short-container-title:Journal of Molecular Biology

Author:

Finch Donna K.,Sleeman Matthew A.,Moisan Jacques,Ferraro Franco,Botterell Sara,Campbell Jamie,Cochrane Duncan,Cruwys Simon,England Elizabeth,Lane Steven,Rendall Elizabeth,Sinha Monisha,Walker Craig,Rees Gareth,Bowen Michael A.,Schneider Amy,Liang Meina,Faggioni Raffaella,Fung Michael,Mallinder Philip R.,Wilkinson Trevor,Kolbeck Roland,Vaughan Tristan,Lowe David C.

Publisher

Elsevier BV

Subject

Molecular Biology,Structural Biology

Reference36 articles.

1. Development trends for human monoclonal antibody therapeutics;Nelson;Nat. Rev. Drug Discov.,2010

2. Development of motavizumab, an ultrapotent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract;Wu;J. Mol. Biol.,2007

3. Demonstration of an in vivo generated sub-picomolar affinity human monoclonal antibody to interleukin-8;Rathanaswami;Biochem. Biophys. Res. Commun.,2005

4. Multiple roles for the major histocompatibility complex I-related receptor FcRn;Ghetie;Annu. Rev. Immunol.,2000

5. Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn);Dall'Acqua;J. Biol. Chem.,2006

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What Have We Learned?;BioDrugs;2023-11-21

2. Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction;Scientific Reports;2023-06-17

3. Tozorakimab (MEDI3506): a dual-pharmacology anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction;2023-03-01

4. Application and prospect of targeting innate immune sensors in the treatment of autoimmune diseases;Cell & Bioscience;2022-05-26

5. Recent Achievements and Challenges in Prolonging the Serum Half-Lives of Therapeutic IgG Antibodies Through Fc Engineering;BioDrugs;2021-02-19